Our Solutions

"Vince & Associates Clinical Research Begins Construction on $5 Million Expansion Project"

News Release FOR MORE INFORMATION
FOR IMMEDIATE RELEASE Bruce Copeland
(913) 696-1601
bcopeland@vinceandassociates.com

(Overland Park, Kan., April 29, 2014) — Vince & Associates Clinical Research, a leading
provider of comprehensive, early development clinical research services for the global
biopharmaceutical industry, broke ground on a new $5 million expansion of its research
campus.
Vince & Associates is recognized for its ability to rapidly and effectively recruit and retain both
special patient populations and healthy normal volunteers in early phase clinical trials. The new
building will house an expanded recruitment center that will support the demand for qualified
subjects as well as benefit clients by further enhancing the company’s ability to recruit for
complex early development clinical trials.
“Our effective recruitment and execution of complex early development trials stem from our
extensive, therapeutically driven database. By consistently meeting our client’s enrollment
milestones, we are able to reliably provide early efficacy data for our clients’ drug development
decisions,” said Dr. Brad Vince, CEO and medical director of Vince & Associates Clinical
Research.
Included in this new three-story building will be an advanced medical/surgical suite for
specialized clinical trial procedures, such as endoscopies, biopsies and EEGs, as well as
luxuriously designed research suites ideal for volunteers participating in overnight clinical trials.
A new, state-of-the-art pharmacy will provide additional capabilities for the extensive drug
preparation methods conducted at Vince & Associates and will include an expanded USP 797
certified clean room that will exceed standards by maintaining an ISO Class V environment.
“The construction of this new three-story building will allow us to keep pace with demand from
the global biopharmaceutical industry as well as provide a clear, strategic advantage for Vince &
Associates in the conduct of complex clinical trials,” said Dr. Vince.
-more-
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research services to the
biopharmaceutical industry for nearly 15 years. The research professionals at Vince &
Associates are proud to be recognized in the industry as a “Center of Research Excellence.”
Vince & Associates currently operates a state-of-the-art, multimillion-dollar, 90-bed clinical
pharmacology unit that combines the ultimate in subject safety and luxury. This early
development unit has the upscale atmosphere necessary for the recruitment and retention of
study volunteers in both short- and long-term clinical trials. From the safety and security of the
controlled access unit to the added features of a movie theater and game rooms, no detail has
been overlooked.
About Altasciences
Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical
Research (Kansas, USA) and Algorithme Pharma (Quebec, Canada). Both organizations
provide comprehensive early stage clinical services in Phase I/IIa, including the necessary
support services in this critical stage of drug development.
More Information
Additional background materials pertaining to Vince & Associates Clinical Research are located
on the corporate website at http://www.vinceandassociates.com/.
# # #

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.

Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.

Learn More